In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s perspective on advanced manufacturing and pharmaceutical quality. He began the ...

How integrated pharmaceutical manufacturing helps CDMOs simplify scale-up, reduce complexity, and move from raw materials to finished dosage forms faster.

For those monitoring innovation pipelines, patent intelligence is becoming a leading indicator of competitive positioning.

While braille is mandatory on all pharmaceutical packaging in Europe, U.S. regulatory agencies remain quiet on the issue, according to Pharmaceutical Processing. The U.S. Food and Drug Administration ...

Continuous pharmaceutical manufacturing represents a significant shift from traditional batch processing, integrating continuous flow methods, advanced process analytical technology (PAT) and ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Digital twins — a digital replica of the factory floor — are an important ...

Merck & Co. will build a $3 billion pharmaceutical manufacturing facility in Elkton, Va. The new site is expected to create 500 jobs, Virginia Gov. Glenn Youngkin and the company announced at a ...

In this interview, Charles Chase, PhD, the VP and Technical Business Development at Asymchem, a technology-focused pharmaceutical manufacturing company, discusses the significant impact of RNA ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Pharmaceutical Contract Development And Manufacturing Organization Cdmo Market Pharmaceutical Contract Development · GlobeNewswire Inc. Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical ...

EMS is one of the most hands‑on and practical automation systems in pharma. It is simultaneously about engineering, regulatory requirements and operator convenience. Proper architecture (local logic ...

FDA PERSPECTIVE: ADVANCED MANUFACTURING AND THE FUTURE OF PHARMACEUTICAL QUALITY In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s ...